http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101841339-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 |
| filingDate | 2016-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101841339-B1 |
| titleOfInvention | A peptide having anticancer activity, pharmaceutical composition and composition of health functional food for prevention and treatment of cancer comprising an effective amount of the peptide |
| abstract | The present invention relates to a peptide having anticancer activity, a pharmaceutical composition for preventing and treating cancer, and a health functional food composition containing the same as an active ingredient. More specifically, the present invention relates to a peptide having binding activity to a transcription factor CP2c, A peptide represented by the following formula (1), a pharmaceutical composition for preventing and treating cancer containing the same as an active ingredient, and a health functional food composition: ≪ SEQ ID NO. Asn-Tyr-Pro-Gln-Arg-Pro. When the peptide according to the present invention and the pharmaceutical composition comprising the same are treated with cancer cells, they can bind to CP2c through the cell membrane with high stability, can inhibit DNA binding ability of CP2c, By inhibiting the activity of CP2c, CP2c-mediated transcriptional activity specific to cancer cells can be inhibited, so that it can be effectively used to specifically treat cancer cells, and can also be used as an additive for health foods for cancer prevention. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102261371-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020204605-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200116394-A |
| priorityDate | 2015-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 211.